Academic Journal

Clinical benefit of PD-1 antibody plus chemotherapy in advanced HER2 negative gastric or gastro-oesophageal junction adenocarcinoma according to PD-L1 levels: Post-hoc analysis of RATIONALE-305 and pooled analysis of individual patient-level data

Bibliographic Details
Title: Clinical benefit of PD-1 antibody plus chemotherapy in advanced HER2 negative gastric or gastro-oesophageal junction adenocarcinoma according to PD-L1 levels: Post-hoc analysis of RATIONALE-305 and pooled analysis of individual patient-level data
Authors: Lai, Ming-YuAff1, Aff2, Wu, Hao-XiangAff3, He, Ming-MingAff1, Aff2, Guan, Wen-LongAff1, Aff2, Xu, ShengAff4, Hu, HanAff5, Xu, Ya-LingAff6, Wang, Feng-HuaAff1, Aff2, IDs13045026018306_cor1, Xu, Rui-HuaAff1, Aff2, IDs13045026018306_cor2, Qiu, Miao-ZhenAff1, Aff2, IDs13045026018306_cor3
Source: Journal of Hematology & Oncology. 19(1)
Database: Springer Nature Journals
Description
ISSN:17568722
DOI:10.1186/s13045-026-01830-6